Triall partners with LTO Network
Triall has partnered with Europe’s leading blockchain platform LTO Network to anchor research data and secure the integrity of clinical trial data. To kickstart this partnership, Triall will anchor the research data of a COVID-19 clinical trial. Long-term Triall partner Sphereon will support Triall with integrating its first product Verial eTMF to the blockchain servers of LTO Network. Moreover, Triall will work closely together with LTO and Sphereon to bring decentralized identities to the Triall ecosystem with the aim of promoting efficiency, trust, and regulatory compliance in the clinical trial industry.
LTO Network (est. 2014) is a hybrid blockchain platform for decentralized workflows and business process automatization. By combining private chains and a public Leased-Proof-of-Stake blockchain, LTO allows business to built GDPR-compliant blockchain-enabled solutions. LTO Network is building blockchain-as-a-service solutions with both privacy and transparency in mind. The project is considered one of the top blockchain platforms worldwide, which is exemplified by an average of 100k daily transactions, a total of 90+ nodes, and more than 60 ecosystem partners.
Triall will utilize LTO Network’s blockchain infrastructure to anchor research data to the blockchain, thereby strengthening the integrity and security of clinical trial data. Moreover, Triall, LTO, and Sphereon will together leverage emerging blockchain standards Decentralized Identifiers and Verifiable Credentials to lay the groundwork for a decentralized identity and access management infrastructure that will integrate the severly fragmented landscape of clinical trial stakeholders and sofware systems.
Through its first commercial product Verial eTMF, Triall will anchor the research data of a COVID-19 clinical trial on the blockchain servers of LTO network — the world’s first COVID-19 clinical trial to be anchored on the blockchain! By integrating with LTO, Triall is expanding its technology stack, which since it’s first succesful product pilot in 2019 has been integrated with the blockchain servers of the Factom Protocol.
“Together, we are building the world’s first clinical-trial software powered by the blockchain that will secure and streamline the development of a safe and affordable future in medicine,” said Rick Schmitz, CEO of LTO Network.
“The ongoing COVID-19 crisis has sparked digital transformation across the pharmaceutical landscape. Our collaboration with LTO Network will pave the way for a range of innovative e-clinical software solutions supporting decentralized clinical trials,” said Hadil Es-Sbai, CEO of Triall
About LTO Network
The LTO Network team is on a mission to create and maintain a fully decentralized and highly efficient blockchain infrastructure, directly applicable and aimed at creating value for organizations. LTO Network can be used by any company with a need for a production-ready blockchain that allows for digital verification of digital assets and enabling collaboration through the use of decentralized workflows.
Sphereon offers a wide array of advanced APIs for document processing and blockchain functions. By offering APIs, they allow organizations to seamlessly connect their business IT systems with multiple blockchain technologies, document and workflows systems, and/or other business applications. Sphereon’s document APIs leverage technologies such as Deep Learning and Natural Language Processing to automatically analyze or classify data objects, photos, and documents and extract data.
Triall brings Web 3.0 to medical research by creating a digital ecosystem of blockchain-integrated software solutions that secure and streamline the development of new vaccines and therapeutics during clinical trials. Triall’s solutions make clinical trials tamper-resistant, and enable secure and efficient integrations between the many isolated systems and parties involved in clinical trial processes. Triall’s software is created by clinical trial professionals to ensure optimal user experience, solving actual industry pain points.